Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technologies, Bio-Rad Reach Licensing Agreement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Idaho Technologies and Bio-Rad Laboratories announced after the close of the market on Tuesday a licensing agreement covering SYBR Green in PCR reactions and high-resolution melting.

Financial and other terms of the deal were not disclosed.

SYBR Green is a product of Life Technologies' Invitrogen business, but Idaho Technologies holds the patent for its use in PCR research, an Idaho Technology official said. During the summer, the company licensed reagents and methods covering the SYBR technology to E.I du Pont de Nemours, commonly known as DuPont.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.